BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31991220)

  • 1. Resistance to third-generation cephalosporins in Escherichia coli in the French community: The times they are a-changin'?
    Jeanvoine A; Bouxom H; Leroy J; Gbaguidi-Haore H; Bertrand X; Slekovec C
    Int J Antimicrob Agents; 2020 May; 55(5):105909. PubMed ID: 31991220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance and clonality in Escherichia coli and Klebsiella spp. and relationship with antibiotic consumption in major Lebanese hospitals.
    Daoud Z; Salem-Sokhn E; Dahdouh E; Irani J; Matar GM; Doron S
    J Glob Antimicrob Resist; 2017 Dec; 11():45-51. PubMed ID: 28756026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates.
    Batard E; Vibet MA; Thibaut S; Corvec S; Pivette J; Lepelletier D; Caillon J; Montassier E
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):271-276. PubMed ID: 29076047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hospital antibiotic use and quinolone resistance in Escherichia coli.
    Batard E; Ollivier F; Boutoille D; Hardouin JB; Montassier E; Caillon J; Ballereau F
    Int J Infect Dis; 2013 Apr; 17(4):e254-8. PubMed ID: 23183232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource-limited settings from Latin America.
    Bartoloni A; Pallecchi L; Riccobono E; Mantella A; Magnelli D; Di Maggio T; Villagran AL; Lara Y; Saavedra C; Strohmeyer M; Bartalesi F; Trigoso C; Rossolini GM
    Clin Microbiol Infect; 2013 Apr; 19(4):356-61. PubMed ID: 22414066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.
    Pitout JD
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1165-76. PubMed ID: 23199402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
    Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Prevalence of Plasmid-Mediated Quinolone Resistance Determinants in Escherichia coli and Klebsiella pneumoniae Isolates from Pediatric Patients in China.
    Xue G; Li J; Feng Y; Xu W; Li S; Yan C; Zhao H; Sun H
    Microb Drug Resist; 2017 Jan; 23(1):107-114. PubMed ID: 27167505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with ciprofloxacin and third-generation cephalosporin versus third-generation cephalosporin monotherapy in Escherichia coli meningitis in infants: a multicentre propensity score-matched observational study.
    Tauzin M; Ouldali N; Lévy C; Béchet S; Cohen R; Caeymaex L
    Clin Microbiol Infect; 2019 Aug; 25(8):1006-1012. PubMed ID: 30593862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There an Association Between Use of Amoxicillin-Clavulanate and Resistance to Third-Generation Cephalosporins in Klebsiella pneumoniae and Escherichia coli at the Hospital Level?
    Marquet A; Vibet MA; Caillon J; Javaudin F; Chapelet G; Montassier E; Batard E
    Microb Drug Resist; 2018 Sep; 24(7):987-994. PubMed ID: 29489447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Class 1 Integrons and Extended Spectrum Beta Lactamases among Multi-Drug Resistant Escherichia coli Isolates from North of Iran.
    Mehdipour Moghaddam MJ; Mirbagheri AA; Salehi Z; Habibzade SM
    Iran Biomed J; 2015; 19(4):233-9. PubMed ID: 26220727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and genetic relatedness of antimicrobial-resistant Escherichia coli isolated from animals, foods and humans in Iceland.
    Thorsteinsdottir TR; Haraldsson G; Fridriksdottir V; Kristinsson KG; Gunnarsson E
    Zoonoses Public Health; 2010 May; 57(3):189-96. PubMed ID: 19912612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of ESBLs among Escherichia coli isolates from outpatients with recurrent UTIs and their antimicrobial resistance.
    Al-Mayahie S; Al Kuriashy JJ
    J Infect Dev Ctries; 2016 Jun; 10(6):575-83. PubMed ID: 27367005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique.
    Estaleva CEL; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Simonsen GS; Haldorsen B; Essack SY; Sundsfjord A
    BMC Infect Dis; 2021 Jan; 21(1):16. PubMed ID: 33407206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observation of a new pattern of mutations in
    Dasgupta N; Paul D; Chanda DD; Chetri S; Chakravarty A; Bhattacharjee A
    Indian J Med Microbiol; 2018; 36(1):131-135. PubMed ID: 29735844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of extended-spectrum β-lactamase-producing multidrug-resistant Escherichia coli among isolates from community-acquired infections and in silico structural modeling of an ESBL protein.
    Rajapandiyan K; Shanthi S; Vijayalakshmi P; Daisy P; Murugan M; Ranjitsingh AJ
    Microb Drug Resist; 2014 Apr; 20(2):170-6. PubMed ID: 24228708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of oral third generation cephalosporins and quinolones and occurrence of antibiotic-resistant strains in the neurogenic bladder (NB) outpatient setting: a retrospective chart audit.
    Kitagawa K; Shigemura K; Nomi M; Takami N; Yamada N; Fujisawa M
    Spinal Cord; 2020 Jun; 58(6):705-710. PubMed ID: 31965059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to quinolones, cephalosporins and macrolides in Escherichia coli causing bacteraemia in Peruvian children.
    Palma N; Pons MJ; Gomes C; Mateu J; Riveros M; García W; Jacobs J; García C; Ochoa TJ; Ruiz J
    J Glob Antimicrob Resist; 2017 Dec; 11():28-33. PubMed ID: 28743651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative epidemiology of E. coli resistance to third-generation cephalosporins in diseased food-producing animals.
    Bourély C; Chauvin C; Jouy É; Cazeau G; Jarrige N; Leblond A; Gay É
    Vet Microbiol; 2018 Sep; 223():72-78. PubMed ID: 30173755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.